NCT03359291View on ClinicalTrials.gov

Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

December 4, 2017

Study Completion Date

December 4, 2017

Conditions
Healthy Subjects
Interventions
DRUG

Rosuvastatin

Single oral dose of 10 mg rosuvastatin (film-coated tablet) on Day 1 and Day 10

DRUG

Macitentan

Single oral dose of 30 mg macitentan (film-coated tablet) on Day 5 and 10 mg macitentan administered orally from Day 6 to Day 16

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim, Mannheim

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY